(Q39644021)

English

What is a safe future liver remnant size in patients undergoing major hepatectomy for colorectal liver metastases and treated by intensive preoperative chemotherapy?

scientific article published on 7 March 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

What is a safe future liver remnant size in patients undergoing major hepatectomy for colorectal liver metastases and treated by intensive preoperative chemotherapy? (English)

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

1 reference

based on heuristic

inferred from title

Elie Oussoultzoglou

2

object named as

Elie Oussoultzoglou

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Patrick Pessaux

4

object named as

Patrick Pessaux

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

author name string

Masato Narita

1

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Pascal Fuchshuber

3

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Marie-Pierre Chenard

5

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Edoardo Rosso

6

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Cinzia Nobili

7

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Daniel Jaeck

8

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Philippe Bachellier

9

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

publication date

7 March 2012

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Annals of Surgical Oncology

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

19

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

2526-2538

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Combination of surgery and chemotherapy and the role of targeted agents in the treatment of patients with colorectal liver metastases: recommendations from an expert panel

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2274-X

21 January 2018

Detection of hematogenous tumor cell dissemination predicts tumor relapse in patients undergoing surgical resection of colorectal liver metastases.

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2274-X

21 January 2018

Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2274-X

21 January 2018

Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2274-X

21 January 2018

Complete response of colorectal liver metastases after chemotherapy: does it mean cure?

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2274-X

21 January 2018

Sinusoidal injury increases morbidity after major hepatectomy in patients with colorectal liver metastases receiving preoperative chemotherapy

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2274-X

21 January 2018

Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2274-X

21 January 2018

Preoperative contralateral portal vein embolization before major hepatic resection is a safe and efficient procedure: a large single institution experience

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2274-X

21 January 2018

Body surface area and body weight predict total liver volume in Western adults

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2274-X

21 January 2018

Nomenclature of hepatic anatomy and resections: a review of the Brisbane 2000 system

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2274-X

21 January 2018

Prediction of mortality rate after major hepatectomy in patients without cirrhosis.

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2274-X

21 January 2018

Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2274-X

21 January 2018

Sinusoidal obstruction syndrome compromises liver regeneration in patients undergoing two-stage hepatectomy with portal vein embolization

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2274-X

21 January 2018

Predicting high grade lesions of sinusoidal obstruction syndrome related to oxaliplatin-based chemotherapy for colorectal liver metastases: correlation with post-hepatectomy outcome.

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2274-X

21 January 2018

Extended hepatectomy in patients with hepatobiliary malignancies with and without preoperative portal vein embolization

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2274-X

21 January 2018

The value of residual liver volume as a predictor of hepatic dysfunction and infection after major liver resection

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2274-X

21 January 2018

Volumetric analysis predicts hepatic dysfunction in patients undergoing major liver resection

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2274-X

21 January 2018

Postoperative liver dysfunction and future remnant liver: where is the limit? Results of a prospective study.

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2274-X

21 January 2018

Two hundred forty consecutive portal vein embolizations before extended hepatectomy for biliary cancer: surgical outcome and long-term follow-up

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2274-X

21 January 2018

Two-stage hepatectomy approach for initially unresectable colorectal hepatic metastases

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2274-X

21 January 2018

Extended preoperative chemotherapy does not improve pathologic response and increases postoperative liver insufficiency after hepatic resection for colorectal liver metastases

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2274-X

21 January 2018

Bevacizumab improves pathologic response and protects against hepatic injury in patients treated with oxaliplatin-based chemotherapy for colorectal liver metastases

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2274-X

21 January 2018

Strategies for safer liver surgery and partial liver transplantation

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2274-X

21 January 2018

Liver failure after major hepatic resection

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2274-X

21 January 2018

Bacterial clearance in the intact and regenerating liver.

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2274-X

21 January 2018

Safe liver resection following chemotherapy for colorectal metastases is a matter of timing

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2274-X

21 January 2018

Effect of portal vein embolisation on the growth rate of colorectal liver metastases

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2274-X

21 January 2018

Two-stage hepatectomy for multiple bilobar colorectal liver metastases

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2274-X

21 January 2018

A report of the Vancouver Forum on the care of the live organ donor: lung, liver, pancreas, and intestine data and medical guidelines

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2274-X

21 January 2018

Remnant liver volume to body weight ratio > or =0.5%: A new cut-off to estimate postoperative risks after extended resection in noncirrhotic liver

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2274-X

21 January 2018

A novel 3D hepatectomy simulation based on liver circulation: application to liver resection and transplantation.

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2274-X

21 January 2018

Impact of preoperative planning using virtual segmental volumetry on liver resection for hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2274-X

21 January 2018

Tumor progression while on chemotherapy: a contraindication to liver resection for multiple colorectal metastases?

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2274-X

21 January 2018

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2274-X

21 January 2018

Identifiers

10.1245/S10434-012-2274-X

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39644021&oldid=2203052114"